Association between chronic kidney disease and small residual urine volumes in patients with benign prostatic hyperplasia

Nephrology

Volumn 16, Issue 3, 2011, Pages 335-339

  Yamasaki, Takeshi ^a   Naganuma, Toshihide ^a   Iguchi, Taro ^a   Kuroki, Yoshikazu ^a   Kuwabara, Nobuyuki ^a   Takemoto, Yoshiaki ^a   Shoji, Tetsuo ^a   Nakatani, Tatsuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

benign prostatic hyperplasia; chronic kidney disease; estimated glomerular filtration rate; post void residual urine

Indexed keywords

CREATININE; NAFTOPIDIL; SILODOSIN; TAMSULOSIN; TERAZOSIN; URAPIDIL;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RESIDUAL URINE; RISK FACTOR; STAGING;

AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KIDNEY; KIDNEY DISEASES; LOGISTIC MODELS; MALE; ODDS RATIO; PREVALENCE; PROSTATIC HYPERPLASIA; RISK ASSESSMENT; RISK FACTORS; URINATION; URODYNAMICS;

EID: 79951961304     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01430.x     Document Type: Article

References (20)

1. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999. J. Am. Soc. Nephrol. 2005; 16: 489-95. (Pubitemid 41725146)
2. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004; 351: 1296-305.
3. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003; 108: 2154-69. (Pubitemid 37337595)
4. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N. Engl. J. Med. 2005; 352: 2049-60. (Pubitemid 40664306)
5. Boyle P, Napalkov P,. The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension. Scand. J. Urol. Nephrol. Suppl. 1995; 168: 7-12.
6. George NJ, O'Reilly PH, Barnard RJ, et al. High pressure chronic retention. Br. Med. J. (Clin. Res. Ed) 1983; 286: 1780-3. (Pubitemid 13096188)
7. Styles RA, Neal DE, Griffiths CJ, et al. Long-term monitoring of bladder pressure in chronic retention of urine: the relationship between detrusor activity and upper tract dilatation. J. Urol. 1988; 140: 330-4.
8. Comiter CV, Sullivan MP, Schacterle RS, et al. Urodynamic risk factors for renal dysfunction in men with obstructive and nonobstructive voiding dysfunction. J. Urol. 1997; 158: 181-5. (Pubitemid 27251620)
9. Rule AD, Lieber MM, Jacobsen SJ,. Is benign prostatic hyperplasia a risk factor for chronic renal failure? J. Urol. 2005; 173: 691-6. (Pubitemid 40239321)
10. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am. J. Kidney Dis. 2009; 53: 982-92.
11. Levey AS,. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39: S1-266.
12. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005; 67: 2089-100. (Pubitemid 41623371)
13. Di Mare JR, Fish SR, Harper JM, et al. Residual urine in normal male subjects. J. Urol. 1966; 96: 180-1.
14. McConnell JD, Barry MJ, Bruskewitz RC,. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research. Clin. Pract. Guidel. Quick Ref. Guide Clin. 1994; 1-17.
15. Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin. Exp. Nephrol. 2009; 13: 621-30.
16. Hong SK, Lee ST, Jeong SJ, et al. Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int. 2010; 105: 1424-8.
17. Neal DE,. Irreversible renal failure in men with outflow obstruction: is it a preventable disease? Postgrad. Med J. 1990; 66: 996-9.
18. Rule AD, Jacobson DJ, Roberts RO, et al. The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men. Kidney Int. 2005; 67: 2376-82. (Pubitemid 41623400)
19. George NJ, Feneley RC, Roberts JB,. Identification of the poor risk patient with 'prostatism' and detrusor failure. Br. J. Urol. 1986; 58: 290-5. (Pubitemid 16076002)
20. Styles RA, Ramsden PD, Neal DE,. Chronic retention of urine. The relationship between upper tract dilatation and bladder pressure. Br. J. Urol. 1986; 58: 647-51. (Pubitemid 17215754)